Skip to main content
Livermore
Livermore
ZHEN

Redmile Group, LLC

SEC CIK
0001425738
Latest filing
Aug 14, 2026

Holdings in Q2 2024

Holdings as of Jun 30, 2024, filed Aug 14, 2024. Long positions only; changes compare share counts with Q1 2024.

Institution overview
Positions
63
−14 vs. Q1 2024
Portfolio value
$1.65B
−$1.07B (−39.3%) vs. Q1 2024
Filed
Aug 14, 2024
SEC
Holdings of Redmile Group, LLC in Q2 2024
SecurityClassSharesValue% of portfolioShare changeActionHistory
KRYSKrystal Biotech, Inc.COM1,021,078$187.5M11.3%−487,172−32.3%ReducedHistory
FOLDAmicus Therapeutics, Inc.COM10,595,089$105.1M6.4%−2,662,197−20.1%ReducedHistory
NRIXNurix Therapeutics, Inc.COM4,423,616$92.3M5.6%−59,400−1.3%ReducedHistory
STOKStoke Therapeutics, Inc.COM4,721,054$63.8M3.9%−351,995−6.9%ReducedHistory
IMNMImmunome Inc.COM4,889,554$59.2M3.6%00.0%UnchangedHistory
RGNXREGENXBIO Inc.COM4,569,802$53.5M3.2%+18,246+0.4%AddedHistory
LIVNLivaNova PLCSHS929,506$51.0M3.1%−108,274−10.4%ReducedHistory
REPLReplimune Group, Inc.COM5,562,096$50.1M3.0%+1,832,113+49.1%AddedHistory
ADCTADC Therapeutics SASHS15,269,217$48.3M2.9%00.0%UnchangedHistory
KYMRKymera Therapeutics, Inc.COM1,579,275$47.1M2.9%−154,814−8.9%ReducedHistory
SRRKScholar Rock Holding CorpCOM5,453,083$45.4M2.7%−966,527−15.1%ReducedHistory
ZYMEZymeworks Inc.COM5,211,037$44.3M2.7%−349,761−6.3%ReducedHistory
FATEFate Therapeutics IncCOM13,169,057$43.2M2.6%00.0%UnchangedHistory
COGTCogent Biosciences, Inc.COM4,799,973$40.5M2.4%+837,371+21.1%AddedHistory
BEAMBeam Therapeutics Inc.COM1,703,061$39.9M2.4%−176,556−9.4%ReducedHistory
SLNSilence Therapeutics plcADS2,014,296$38.3M2.3%−13,373−0.7%ReducedHistory
AKROAkero Therapeutics, Inc.COM1,614,473$37.9M2.3%−244,229−13.1%ReducedHistory
BHVNBiohaven Ltd.COM1,087,576$37.7M2.3%−75,665−6.5%ReducedHistory
NGNENeurogene Inc.COM1,013,663$36.9M2.2%+78,411+8.4%AddedHistory
PLRXPliant Therapeutics, Inc.COM3,209,591$34.5M2.1%+112,371+3.6%AddedHistory
CTLTCatalent, Inc.COM595,570$33.5M2.0%−36,894−5.8%ReducedHistory
ANNXAnnexon, Inc.COM6,427,462$31.5M1.9%+924,272+16.8%AddedHistory
BSXBoston Scientific CorpStock390,253$30.1M1.8%−170,673−30.4%ReducedHistory
IDYAIDEAYA Biosciences, Inc.COM759,516$26.7M1.6%−163,162−17.7%ReducedHistory
CLDXCelldex Therapeutics, Inc.COM NEW718,723$26.6M1.6%−177,731−19.8%ReducedHistory
ABSIAbsci CorpCOM8,253,316$25.4M1.5%00.0%UnchangedHistory
KROSKeros Therapeutics, Inc.COM552,506$25.2M1.5%00.0%UnchangedHistory
ALXOAlx Oncology Holdings IncCOM4,036,451$24.3M1.5%−290,058−6.7%ReducedHistory
FDMT4D Molecular Therapeutics, Inc.COM1,073,435$22.5M1.4%−187,992−14.9%ReducedHistory
STTKShattuck Labs, Inc.COM5,615,489$21.7M1.3%00.0%UnchangedHistory
IGMSIGM Biosciences, Inc.COM3,072,478$21.1M1.3%00.0%UnchangedHistory
IMVTImmunovant, Inc.COM720,177$19.0M1.1%−249,444−25.7%ReducedHistory
ISRGIntuitive Surgical IncCOM NEW39,843$17.7M1.1%+10,297+34.9%AddedHistory
AUGXAugmedix, Inc.COM16,380,327$14.4M0.9%00.0%UnchangedHistory
ETNB89bio, Inc.COM1,745,656$14.0M0.8%−518,910−22.9%ReducedHistory
ARDXArdelyx, Inc.COM1,881,501$13.9M0.8%−313,059−14.3%ReducedHistory
SYKStryker CorpStock39,483$13.4M0.8%−3,763−8.7%ReducedHistory
PRMEPrime Medicine, Inc.COM2,074,350$10.7M0.6%00.0%UnchangedHistory
BPMCBlueprint Medicines CorpCOM94,405$10.2M0.6%−18,655−16.5%ReducedHistory
ESTAEstablishment Labs Holdings Inc.COM213,024$9.68M0.6%+98,683+86.3%AddedHistory
NUVBNuvation Bio Inc.COM CL A3,031,009$8.85M0.5%00.0%UnchangedHistory
TRDAEntrada Therapeutics, Inc.COM560,971$7.99M0.5%−722,764−56.3%ReducedHistory
ACIUAC Immune SASHS1,807,704$7.21M0.4%−199,327−9.9%ReducedHistory
VERVVerve Therapeutics, Inc.COM1,463,406$7.14M0.4%−141,109−8.8%ReducedHistory
RPTXRepare Therapeutics Inc.COM1,942,555$6.41M0.4%−73,747−3.7%ReducedHistory
CYTKCytokinetics IncCOM NEW111,867$6.06M0.4%−49,733−30.8%ReducedHistory
VTYXVentyx Biosciences, Inc.COM2,164,126$5.00M0.3%00.0%UnchangedHistory
BOLDBoundless Bio, Inc.COM1,034,583$4.00M0.2%−79,451−7.1%ReducedHistory
ATRAAtara Biotherapeutics, Inc.COM NEW452,270$3.84M0.2%+81,738+22.1%AddedConverted for a 1-for-25 splitHistory
STXSStereotaxis, Inc.COM NEW2,108,219$3.84M0.2%−1,200,579−36.3%ReducedHistory
LVTXLAVA Therapeutics NVSHS2,074,372$3.73M0.2%00.0%UnchangedHistory
IVVDInvivyd, Inc.COM3,065,714$3.37M0.2%+1,624,989+112.8%AddedHistory
CABACabaletta Bio, Inc.COM442,826$3.31M0.2%00.0%UnchangedHistory
GRTSGritstone bio, Inc.COM5,107,732$3.16M0.2%−647,343−11.2%ReducedHistory
ALLKAllakos Inc.COM3,077,828$3.08M0.2%−373,248−10.8%ReducedHistory
XERSXeris Biopharma Holdings, Inc.COM1,046,587$2.35M0.1%00.0%UnchangedHistory
RAPTRAPT Therapeutics, Inc.COM536,682$1.64M0.1%−125,716−19.0%ReducedHistory
KLRSKalaris Therapeutics, Inc.COM1,907,969$1.38M0.1%00.0%UnchangedHistory
Achilles Therapeutics PLC00449L102SPONSORED ADS1,608,089$1.31M0.1%00.0%Unchanged–
LABStandard Biotools Inc.COM411,631$728.6K<0.1%00.0%UnchangedHistory
ADAPYAdaptimmune Therapeutics PLCSPONDS ADR715,607$697.6K<0.1%00.0%UnchangedHistory
HOOKHOOKIPA Pharma Inc.COM1,063,769$629.5K<0.1%00.0%UnchangedHistory
TKNOAlpha Teknova, Inc.COM154,509$211.7K<0.1%−16,944−9.9%ReducedHistory

Sold out since Q1 2024 (14)

Positions held at the end of Q1 2024 that are gone from this filing.

Positions of Redmile Group, LLC sold out since Q1 2024
SecurityClassShares in Q1 2024Value in Q1 2024% of portfolio in Q1 2024History
DCPHDeciphera Pharmaceuticals, Inc.COM5,296,643$83.3M3.1%History
ABTAbbott LaboratoriesStock262,371$29.8M1.1%History
ALGNAlign Technology IncCOM87,255$28.6M1.1%History
CICigna GroupStock65,435$23.8M0.9%History
EVHEvolent Health, Inc.CL A679,172$22.3M0.8%History
HCAHCA Healthcare, Inc.COM52,487$17.5M0.6%History
ELVElevance Health, Inc.Stock31,223$16.2M0.6%History
ICLRIcon PLCCOM36,949$12.4M0.5%History
PGNYProgyny, Inc.COM320,864$12.2M0.4%History
DGXQuest Diagnostics IncCOM83,849$11.2M0.4%History
MCKMcKesson CorpStock20,707$11.1M0.4%History
ELANElanco Animal Health IncCOM676,039$11.0M0.4%History
PENPenumbra IncCOM44,613$9.96M0.4%History
APLSApellis Pharmaceuticals, Inc.COM155,000$9.11M0.3%History